About Cryo-Cell
Investor Relations
A healthy investment in healthier futures.
Cryo-Cell has been a publicly traded company since 1991. Governed by the Securities & Exchange Commission, our common stock trades under the OTC Bulletin Board symbol CCEL. We specialize in U-Cord® stem cell preservation for family use.
Press Releases
8/23/2010
Cryo-Cell Announces Progress with Strategic Partner S-Evans Biosciences, Inc.
8/17/2010
8/16/2010
Cryo-Cell International to Explore Strategic Acquisition Opportunities
7/15/2010
Cryo-Cell International, Inc. Reports Second Quarter 2010 Results
5/6/2010
Endometrial Stem Cells Restore Brain Dopamine Levels
4/13/2010
Cryo-Cell International, Inc. Reports First Quarter 2010 Results
4/5/2010
Stem Cells From Menstrual Blood May Benefit Stroke Patients
3/29/2010
Read more articles in the Archive
Financial Highlights
Section 16 Filings: All Insiders
Annual Reports
Quarterly & Other Reports
Stock Quote
Fundamentals
News
Chart
Real-Time Filings
Webcasts
Featured in
Upromise.com: helping you save for your children’s education through family blood banking (only with Cryo-Cell).
Partners
Wake Forest University | Duke University | Stanford University | University of South Florida | American College of Obstetricians & Gynecologists | American College of Nurses & Midwives | Florida Blood Services | National Hispanic Medical Association | Google | Yahoo | Cryo-Cell Latin America & Asia | Babyzone.com
As seen on
Facebook
TwitterBookmark this
Copyright © 2008 Cryo-Cell International, Inc. All Rights Reserved. Privacy Policy | Site Map
Web Design & Digital Marketing Solutions provided by Horizon Marketing Group, Inc.